Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2025-02-10 00:00:00 ET · period of report 2025-02-06 · accession 0001415889-25-003515 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-02-10 | 2025-02-07 | ELVN | Patel Anish | COO | S - Sale | $21.93 | -6,667 | 330.0K | -2% | -$146.2K |
| D | 2025-02-10 | 2025-02-06 | ELVN | Patel Anish | COO | A - Grant | $0.00 | +171.0K | 171.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-07 | S | D | 6,667 | $21.93 | 329,977 | I See footnote | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $21.655 to $22.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F3) The shares are held by The Patel / Dong Family Trust. |
| 2 | Derivative | Stock Option (right to buy) | 2025-02-06 | A | A | 171,000 | $0.00 | 171,000 | D | $22.47 · — to 2035-02-06 | 171,000 Common Stock | (F4) 1/4th of the shares subject to the option will vest on February 6, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |